← Back to Search
Glycosylated Diazeniumdiolates: A Novel Class Of Enzyme-activated Nitric Oxide Donors
Xuejun Wu, X. Tang, M. Xian, P. Wang
Published 2001 · Chemistry
Download PDFAnalyze on Scholarcy
Abstract Synthetic procedures have been developed to attach the nitric oxide releasing diazeniumdiolate functional groups [N(O)NO] − to a carbohydrate unit. These glycosylated diazeniumdiolates exhibited significantly improved stability as compared to their parent diazeniumdiolate salts, yet they could readily release nitric oxide upon activation by glycosidases. Preliminary antitumor screen assay demonstrated that this class of compounds had antitumor activity.
This paper references
Nitric Oxide (NO) Donor Molecules: Effect of NO Release Rate on Vascular Smooth Muscle Cell Proliferation In Vitro
D. Mooradian (1995)
Nitric Oxide‐Releasing Compounds: From Basic Research to Promising Drugs
L. Keefer (1998)
Synthesis of peptide-diazeniumdiolate conjugates: towards enzyme activated antitumor agents
X. Tang (2001)
Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver.
J. Saavedra (1997)
In vitro screening model for the detection of agents active against myelogenous leukemia.
M. Edelstein (1998)
Secondary amine/nitric oxide complex ions, R2N[N(O)NO]-. O-functionalization chemistry
J. Saavedra (1992)
Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators.
D. Morley (1993)
Diazeniumdiolates: pro- and antioxidant applications of the "NONOates".
A. Fitzhugh (2000)
Antitumor activity of a novel glyco‐nitric oxide conjugate in ovarian carcinoma
G. Cantuaria (2000)
"NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms.
L. Keefer (1996)
Glyco-S-nitrosothiols, a novel class of NO donor compounds
J. Ramirez (1996)
DNA sequence changes induced by two nitric oxide donor drugs in the supF assay.
M. Routledge (1994)
Piperazine as a Linker for Incorporating the Nitric Oxide-Releasing Diazeniumdiolate Group into Other Biomedically Relevant Functional Molecules
J. Saavedra (1999)
The synthesis and cytotoxicity of fructose-1-SNAP, a novel fructose conjugated S-nitroso nitric oxide donor
Yongchun Hou (2001)
The Reaction of Nitrogen(II) Oxide with Diethylamine
R. S. Drago (1960)
Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: antiplatelet effect.
J. Diodati (1993)
Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity.
J. Saavedra (2000)
This paper is referenced by
Synergistic interaction of β-galactosyl-pyrrolidinyl diazeniumdiolate with cisplatin against three tumor cells
Lingling Deng (2013)
Synthesis of cephalosporin-3'-diazeniumdiolates: biofilm dispersing NO-donor prodrugs activated by β-lactamase.
N. Yepuri (2013)
Enzyme-functionalized vascular grafts catalyze in-situ release of nitric oxide from exogenous NO prodrug.
Zhihong Wang (2015)
Nitrous oxide as a primary product in base-mediated β-elimination reactions of diazeniumdiolated benzylamine derivatives.
Debanjan Biswas (2012)
Novel α-ketoamide based diazeniumdiolates as hydrogen peroxide responsive nitric oxide donors with anti-lung cancer activity.
Junjie Fu (2019)
Prodrug design for the potent cardiovascular agent Nω-hydroxy-L-arginine (NOHA): synthetic approaches and physicochemical characterization.
D. Schade (2011)
Arylation of Sensitive 1-(Pyrrolidin-1-yl)-diazen-1-ium-diolate in Ionic Liquids
C. Velázquez (2010)
Tailored Synthesis of Nitric Oxide-Releasing Polyurethanes Using O-Protected Diazeniumdiolated Chain Extenders.
M. Reynolds (2010)
Sialated diazeniumdiolate: a new sialidase-activated nitric oxide donor.
T. B. Cai (2004)
Hydrolytic Reactivity Trends among Potential Prodrugs of the O2-Glycosylated Diazeniumdiolate Family. Targeting Nitric Oxide to Macrophages for Antileishmanial Activity
C. Valdez (2008)
Abgrenzung der verschiedenen Schadensersatzansprüche
Long Jiang (2001)
NSAID-Diazeniumdiolate - Hybridarzneistoffe als direkte NO- Donatoren
T. Winkler (2006)
The renaissance of nitric oxide: from improvement of stability to enhancement of endocytosis
F. Jia (2018)
Glycosylated Diazeniumdiolates: A Novel Class of Enzyme‐Activated Nitric Oxide Donors.
X. Wu (2001)
A small molecule for theraNOstic targeting of cancer cells.
G. Ravikumar (2017)
Recent developments in nitric oxide donor drugs
M. Miller (2007)
Nitric oxide donor drugs: current status and future trends
D. Webb (2002)
Delivery of Nitric Oxide Released from β-Gal-NONOate Activation by β-Galactosidase and Its Activity against Escherichia coli
C. Chen (2006)
Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
Junjie Fu (2013)
Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates.
L. Keefer (2003)
NO donor hybrid compounds as multifunctional therapeutic agents
L. Fang (2008)
Npom‐Protected NONOate Enables Light‐Triggered NO/cGMP Signalling in Primary Vascular Smooth Muscle Cells
Anna S Stroppel (2018)
Application of Mono‐ and Disaccharides in Drug Targeting and Efficacy
S. Yu-an (2018)
Nitrogen-bound diazeniumdiolated amidines.
Debanjan Biswas (2010)
A Glycosylated Nitric Oxide Donor, β‐Gal‐NONOate, and its Site‐specific Antitumor Activity
C. Chen (2006)
J. Park (2017)
Glycosylated diazeniumdiolate-based oleanolic acid derivatives: synthesis, in vitro and in vivo biological evaluation as anti-human hepatocellular carcinoma agents.
Zhangjian Huang (2012)
Nitric-Oxide-Releasing Biomaterial Regulation of the Stem Cell Microenvironment in Regenerative Medicine.
Adam C Midgley (2019)
Progress and Promise of Nitric Oxide‐Releasing Platforms
T. Yang (2018)
Synthesis of beta-lactamase activated nitric oxide donors.
X. Tang (2003)
Nitrosation of sugar oximes: preparation of 2-glycosyl-1-hydroxydiazene-2-oxides.
J. Brand (2005)
O2-(6-Oxocyclohex-1-en-1-yl)methyl diazen-1-ium-1,2-diolates: a new class of nitric oxide donors activatable by GSH/GSTπ with both anti-proliferative and anti-metastatic activities against melanoma.
Chengfeng Bai (2017)See more